"Just right" combinations of adjuvants with nanoscale carriers activate aged dendritic cells without overt inflammation.

Background: The loss in age-related immunological markers, known as immunosenescence, is caused by a combination of factors, one of which is inflammaging. Inflammaging is associated with the continuous basal generation of proinflammatory cytokines. Studies have demonstrated that inflammaging reduces the effectiveness of vaccines.